Arnoldo L.; Cattani G.; Cojutti P.; Pea F.; Brusaferro S., Monitoring polypharmacy in healthcare systems through a multi-setting survey: Should we put more attention on long term care facilities?, «JOURNAL OF PUBLIC HEALTH RESEARCH», 2016, 5, Article number: 745, pp. 104 - 108 [articolo]
Cojutti P.; Arnoldo L.; Cattani G.; Brusaferro S.; Pea F., Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs?, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2016, 25, pp. 1070 - 1078 [articolo]
Cojutti P.; Candoni A.; Forghieri F.; Isola M.; Zannier M.E.; Bigliardi S.; Luppi M.; Fanin R.; Pea F., Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2016, 118, pp. 474 - 479 [articolo]
Cojutti P.; Scarparo C.; Sartor A.; Coato P.; Rigoli R.; Pea F., A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy, «DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE», 2015, 81, pp. 53 - 56 [articolo]
Pea, Federico; Cojutti, Pier Giorgio, Drugs and blood cells, in: Hematologic Problems in the Critically Ill, Milan, Springer-Verlag Milan, 2015, pp. 111 - 147 [commento giuridico]
Pea F.; Cojutti P.; Tursi V.; Livi U.; Baraldo M., Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia, «TRANSPLANT INFECTIOUS DISEASE», 2015, 17, pp. 926 - 928 [replica/breve intervento]
Cojutti P.; Crapis M.; Bassetti M.; Hope W.; Pea F., Linezolid underexposure in a patient co-treated with venlafaxine, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2015, 71, pp. 1285 - 1286 [articolo]
Cojutti P.; Maximova N.; Crichiutti G.; Isola M.; Pea F., Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: A step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2015, 70, Article number: dku337, pp. 198 - 206 [articolo]
Pai M.P.; Cojutti P.; Pea F., Pharmacokinetics and Pharmacodynamics of Continuous Infusion Meropenem in Overweight, Obese, and Morbidly Obese Patients with Stable and Unstable Kidney Function: A Step Toward Dose Optimization for the Treatment of Severe Gram-Negative Bacterial Infections, «CLINICAL PHARMACOKINETICS», 2015, 54, pp. 933 - 941 [articolo]
Cojutti P.; Maximova N.; Pea F., Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2015, 59, pp. 5535 - 5541 [articolo]
Pea F.; Crapis M.; Cojutti P.; Bassetti M., Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia, «INFECTION», 2014, 42, pp. 207 - 210 [articolo]
Pea F.; Dose L.; Cojutti P.; Baraldo M.; Fontana F.; Favaretti C.; Furlanut M., Educational and organizational interventions to improve the usefulness of clinical pharmacological advice for personalized drug dosing based on therapeutic drug monitoring, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2014, 115, pp. 432 - 437 [articolo]
Pea F.; Righi E.; Cojutti P.; Carnelutti A.; Baccarani U.; Soardo G.; Bassetti M., Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2014, 69, pp. 2585 - 2586 [replica/breve intervento]
Pai M.P.; Cojutti P.; Pea F., Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m2) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoring, «CLINICAL PHARMACOKINETICS», 2014, 53, pp. 753 - 762 [articolo]
Pea F.; Cadeo B.; Cojutti P.G.; Pecori D.; Bassetti M., Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report, «THERAPEUTIC DRUG MONITORING», 2014, 36, pp. 687 - 689 [articolo]
